Literature DB >> 24637643

Following in real time the impact of pneumococcal virulence factors in an acute mouse pneumonia model using bioluminescent bacteria.

Malek Saleh1, Mohammed R Abdullah1, Christian Schulz1, Thomas Kohler1, Thomas Pribyl1, Inga Jensch1, Sven Hammerschmidt2.   

Abstract

Pneumonia is one of the major health care problems in developing and industrialized countries and is associated with considerable morbidity and mortality. Despite advances in knowledge of this illness, the availability of intensive care units (ICU), and the use of potent antimicrobial agents and effective vaccines, the mortality rates remain high(1). Streptococcus pneumoniae is the leading pathogen of community-acquired pneumonia (CAP) and one of the most common causes of bacteremia in humans. This pathogen is equipped with an armamentarium of surface-exposed adhesins and virulence factors contributing to pneumonia and invasive pneumococcal disease (IPD). The assessment of the in vivo role of bacterial fitness or virulence factors is of utmost importance to unravel S. pneumoniae pathogenicity mechanisms. Murine models of pneumonia, bacteremia, and meningitis are being used to determine the impact of pneumococcal factors at different stages of the infection. Here we describe a protocol to monitor in real-time pneumococcal dissemination in mice after intranasal or intraperitoneal infections with bioluminescent bacteria. The results show the multiplication and dissemination of pneumococci in the lower respiratory tract and blood, which can be visualized and evaluated using an imaging system and the accompanying analysis software.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24637643      PMCID: PMC4130511          DOI: 10.3791/51174

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  37 in total

Review 1.  How contagious are common respiratory tract infections?

Authors:  Daniel M Musher
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children.

Authors:  D Bogaert; A van Belkum; M Sluijter; A Luijendijk; R de Groot; H C Rümke; H A Verbrugh; P W M Hermans
Journal:  Lancet       Date:  2004-06-05       Impact factor: 79.321

Review 3.  Impact of conjugate pneumococcal vaccines.

Authors:  Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2005-08       Impact factor: 2.129

4.  Sequence of the adenine methylase gene of the Streptococcus faecalis plasmid pAM beta 1.

Authors:  J Brehm; G Salmond; N Minton
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

5.  A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease.

Authors:  J Gerber; G Raivich; A Wellmer; C Noeske; T Kunst; A Werner; W Brück; R Nau
Journal:  Acta Neuropathol       Date:  2001-05       Impact factor: 17.088

Review 6.  Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management.

Authors:  Keith Cartwright
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

7.  The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization.

Authors:  Peter W M Hermans; Peter V Adrian; Christa Albert; Silvia Estevão; Theo Hoogenboezem; Ingrid H T Luijendijk; Thilo Kamphausen; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

8.  The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence.

Authors:  A R Holmes; R McNab; K W Millsap; M Rohde; S Hammerschmidt; J L Mawdsley; H F Jenkinson
Journal:  Mol Microbiol       Date:  2001-09       Impact factor: 3.501

9.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

10.  Tissue-specific contributions of pneumococcal virulence factors to pathogenesis.

Authors:  Carlos J Orihuela; Geli Gao; Kevin P Francis; Jun Yu; Elaine I Tuomanen
Journal:  J Infect Dis       Date:  2004-09-21       Impact factor: 5.226

View more
  6 in total

1.  Regulation of the arginine deiminase system by ArgR2 interferes with arginine metabolism and fitness of Streptococcus pneumoniae.

Authors:  Christian Schulz; Philipp Gierok; Lothar Petruschka; Michael Lalk; Ulrike Mäder; Sven Hammerschmidt
Journal:  MBio       Date:  2014-12-23       Impact factor: 7.867

2.  Modular Architecture and Unique Teichoic Acid Recognition Features of Choline-Binding Protein L (CbpL) Contributing to Pneumococcal Pathogenesis.

Authors:  Javier Gutiérrez-Fernández; Malek Saleh; Martín Alcorlo; Alejandro Gómez-Mejía; David Pantoja-Uceda; Miguel A Treviño; Franziska Voß; Mohammed R Abdullah; Sergio Galán-Bartual; Jolien Seinen; Pedro A Sánchez-Murcia; Federico Gago; Marta Bruix; Sven Hammerschmidt; Juan A Hermoso
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

Review 3.  Selective substrate uptake: The role of ATP-binding cassette (ABC) importers in pathogenesis.

Authors:  Kari J Tanaka; Saemee Song; Kevin Mason; Heather W Pinkett
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-08-25       Impact factor: 3.747

4.  Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation.

Authors:  Franziska Voß; Thomas P Kohler; Tanja Meyer; Mohammed R Abdullah; Fred J van Opzeeland; Malek Saleh; Stephan Michalik; Saskia van Selm; Frank Schmidt; Marien I de Jonge; Sven Hammerschmidt
Journal:  Front Immunol       Date:  2018-10-18       Impact factor: 7.561

5.  Extracellular Pneumococcal Serine Proteases Affect Nasopharyngeal Colonization.

Authors:  Murtadha Q Ali; Thomas P Kohler; Gerhard Burchhardt; Andreas Wüst; Nadin Henck; Robert Bolsmann; Franziska Voß; Sven Hammerschmidt
Journal:  Front Cell Infect Microbiol       Date:  2021-02-15       Impact factor: 5.293

6.  Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.

Authors:  Sarah Berger; Cengiz Goekeri; Shishir K Gupta; Julio Vera; Kristina Dietert; Ulrike Behrendt; Jasmin Lienau; Sandra-Maria Wienhold; Achim D Gruber; Norbert Suttorp; Martin Witzenrath; Geraldine Nouailles
Journal:  Crit Care       Date:  2018-11-01       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.